SB 203580
SB 203580 is a specific inhibitor of p38α and p38β which suppresses downstream activation of MAPKAP kinase-2 and heat shock protein 27. At low concentrations, it does not inhibit JNK activity.
![]() | |
| Names | |
|---|---|
| IUPAC name
4-[4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-1H-imidazol-5-yl]pyridine | |
| Other names
RWJ-64809; | |
| Identifiers | |
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.214.849 |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C21H16FN3OS | |
| Molar mass | 377.43 g/mol |
| Appearance | White to off-white solid |
| Solubility in DMSO | 50 mg/mL |
| Hazards | |
| Main hazards | Xn |
| R-phrases (outdated) | R22 R41 |
| S-phrases (outdated) | S26 S39 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
